Latest filing published 29 Nov 2023 for Tandem Diabetes Care INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David B. Berger, listed as senior executive, appears in our data through filings on Tandem Diabetes Care Inc shares, published by SEC (Form 4). The record holds 32 filings, for trades running from 17 May 2021 to 27 November 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 29 November 2023 came the latest disclosure, an option exercise in Tandem Diabetes Care Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 32 declarations